What this is:
- I'm working on a startup called Nanocytronic whose mission is to build the world’s most advanced in vivo nano-bioengineering tools.
- A few months ago, we pivoted from a failed attempt at functionalising nanowires for this purpose, to now building Drexlerian nanomechanical devices that offer much finer control over matter in the nm regimes. Read about the pivot here.
- We're currently exploring the possibility of building molecular machines that fabricate parts out of glucose precursors, transforming them into crystalline cellulose nanoparts that can later be incorporated as components of a nanofactory and other nanoassembled products (like medical nanorobots). Basically, we're trying to build nanomachines out of glucose molecules xD
- The team is currently me(Colin) & a few scientific advisors.
Below is our roadmap of capabilities.
| Phase | Description/Goal | Timelines | Notes Upon Completion |
|---|---|---|---|
| Phase one | Theoretical characterisation of part fabrication, functionalising and assembly strategies. | Feb 2026 - March 2026 | Phase One Complete |
| Phase two | Computational validation of nanoreactor chemistry | April 2026 - TBD | add later |
| Phase three | Demonstration of core molecular manufacturing chemistry with hardware | TBD | add later |
| Phase four | Product V1: Nanofactory part production | TBD | add later |
| Phase five | Product V2: Medical nanomachines and niche-purpose NEMs | TBD | add later |
| Phase six | Product V3: General purpose high performance materials | TBD | add later |
Potentially Useful R&D side projects we're interested in:
- Switching out our glucose chemistry for higher performance alternatives (stronger linkers, smaller monomers, etc.)
- Building diamondoid nanoparticles via self assembly